Two Medicaid policies can interact to increase oncology clinical trial enrollment among Black and Hispanic patients, according to a new study by investigators at Weill Cornell Medicine, the University ...

Clinical trial enrollment is vital for advancing renal cell carcinoma treatment, providing access to innovative therapies and potentially better care. The STELLAR-002 study evaluated zanzalintinib ...

LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat ...

NEW YORK--(BUSINESS WIRE)--Massive Bio, a cutting-edge AI driven clinical trial matching platform provider, and Foundation Medicine, Inc. today announced a strategic collaboration to increase patient ...

Please provide your email address to receive an email when new articles are posted on . Significant response to trial enrollment observed after individuals received an invitation based on ...

Antidote Technologies, a digital patient engagement company, announced it is partnering with SEQSTER, a multidimensional healthcare data platform, to identify patients for clinical trials and improve ...

Melanie Sheen, MD, describes efforts to boost diverse clinical trial enrollment through trust, community partnerships, and equitable patient engagement. Clinical trial enrollment has nearly doubled in ...

Cytokinetics, Incorporated has announced the enrollment opening for AMBER-HFpEF, a Phase 2 randomized, placebo-controlled clinical trial evaluating the safety and tolerability of CK-586 in patients ...

Clinical trials continue to shape metastatic breast cancer treatment, making therapies safer, more tolerable, and more ...

Patient enrollment in clinical trials sponsored by the National Cancer Institute dropped significantly in March when the country experienced a surge in COVID-19 cases, a new study shows. The study, ...

uniQure N.V. announced that its Independent Data Monitoring Committee (IDMC) has reviewed the safety data from the first cohort of its Phase I/II clinical trial for AMT-162, a gene therapy aimed at ...